BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 105 filers reported holding BIOSCRIP INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $40,910,000 | +50.3% | 15,734,496 | +15.6% | 0.41% | +41.9% |
Q1 2019 | $27,224,000 | -51.0% | 13,611,958 | -12.6% | 0.29% | -63.0% |
Q4 2018 | $55,589,000 | +16.6% | 15,571,146 | +1.2% | 0.79% | +61.9% |
Q3 2018 | $47,695,000 | +5.5% | 15,385,631 | -0.3% | 0.49% | -0.2% |
Q2 2018 | $45,212,000 | +17.4% | 15,430,807 | -1.4% | 0.49% | +2.1% |
Q1 2018 | $38,500,000 | -15.3% | 15,650,368 | +0.2% | 0.48% | -21.9% |
Q4 2017 | $45,469,000 | +4.9% | 15,625,055 | -0.9% | 0.61% | +0.3% |
Q3 2017 | $43,352,000 | +5.0% | 15,764,337 | +3.6% | 0.61% | -0.3% |
Q2 2017 | $41,298,000 | +456.4% | 15,211,136 | +248.4% | 0.61% | +388.8% |
Q1 2017 | $7,422,000 | -60.1% | 4,365,726 | +62.0% | 0.12% | -53.9% |
Q3 2014 | $18,624,000 | -30.2% | 2,695,258 | -15.8% | 0.27% | -23.4% |
Q2 2014 | $26,691,000 | +24.0% | 3,200,397 | +3.7% | 0.35% | +20.8% |
Q1 2014 | $21,533,000 | -25.9% | 3,084,938 | -21.4% | 0.29% | -29.4% |
Q4 2013 | $29,060,000 | -33.0% | 3,927,009 | -20.5% | 0.42% | -38.8% |
Q3 2013 | $43,385,000 | -99.9% | 4,941,296 | +8.4% | 0.68% | -52.2% |
Q2 2013 | $75,222,989,000 | – | 4,558,969 | – | 1.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |